China Takes Major Step On Commercial Insurance For Innovative Drugs But Hurdles Ahead

A boat is trying to move through blocks
Further policy incentives remain key to unlocking commercial health insurance’s true potential for innovative drug coverage. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from China